In Texas, Aprima Medical Software is integrating the ActX Genomic Decision Support platform into its electronic health records and should have it available later this summer. Used by medical practices, Aprima’s software will now allow clinics and doctors to access patient genomics information from their offices to improve personalized patient care, including prescription drug interaction alerts based on patients’ genetic profiles. Andrew Ury M.D., ActX CEO, told PR Newswire, “We are proud to help Aprima make genomics a practical part of everyday medical care by building genomic decision support into their normal physician workflow.” By having this genetic information available in the medical office, doctors can ensure they have considered hereditary risks and genomic profiles before prescribing medications or other treatments.
Latest article
World Animal Protection launches AI-Powered cultivated meat chatbot
In London, animal advocacy group World Animal Protection has partnered with AI software company PubTrawlr to unveil Cultivator, the first-ever chatbot dedicated to cultivated...
DOE awards Hempitecture $8.42 million to boost hemp fiber manufacturing in Tennessee
In Idaho, sustainable building materials firm Hempitecture has been awarded $8.42 million in funding from the U.S. Department of Energy under the Biden-Harris Administration’s...
CJ Biomaterials PHA earns compostability certification
In Massachusetts, CJ Biomaterials, a division of South Korea's CJ CheilJedang, has received certification from the Biodegradable Products Institute (BPI) for its range of...